REFERENCES
- Eliss F D, Wasserman B N, Hidaji F. Selected surgical complications. Clinical Strabismus Management, A L Rosenbaum, A P Santiago. WB Saunders, Philadelphia, PA 1999; 548–550
- Kivlin J D, Wilson M E, Jr. Periocular infection after strabismus surgery: The Periocular Infection Study Group. J Pediatr Ophthalmol Strabismus 1995; 32: 42–49
- Ing M R. Infection following strabismus surgery. Ophthalmic Surg 1991; 22: 41–43
- von Noorden G K. Principles of surgical treatment. Binocular Vision and Ocular Motility, 5th ed., G K von Noorden. Mosby, St. Louis, MO 1996; 573–574
- Wadworth A N, Goa K L. Lomefloxacin: A review of its antibacterial activity, pharmacokinetic properties, and therapeutic use. Drugs 1991; 42: 1018–1060
- Smith A, Pennefather P M, Kaye S B, et al. Fluoroquinolones and place in ocular therapy. Drugs 2001; 61: 747–761
- Perea E J, Garcia I, Pascual A. Comparative penetration of lomefloxacin and other quinolones into human phagocytes. Am J Med 1992; 92(Suppl 4A)48A–51S
- Jauch A, Fsadni M, Gamba G. Meta-analysis of six clinical phase III studies comparing lomefloxacin 0.3% eye drops twice daily to five standard antibiotics in patients with acute bacterial conjunctivitis. Graefe's Arch Clin Exp Ophthalmol 1999; 237: 705–713
- Kowalski R P, Romanowski E G, Yates K A, et al. Lomefloxacin is an effective treatment of experimental bacterial keratitis. Cornea 2001; 20: 306–308
- Velpandian T, Gupta S K, Gupta Y K, et al. Comparative studies on topical lomefloxacin and ciprofloxacin on ocular kinetic and experimental corneal ulcer. J Ocular Pharmacol Therapeut 1999; 15: 505–511
- Gallenga P E, Lobefalo L, Colangelo L, et al. Topical lomefloxacin 0.3% twice daily versus tobramycin 0.3% in acute bacterial conjunctivitis: A multicenter double-blind phase III study. Ophthalmologica 1999; 213: 250–257
- Agius-Fernandez A, Patterson A, Fsadni M, et al. Topical lomefloxacin versus topical chloramphenicol in the treatment of acute bacterial conjunctivitis. Clin Drug Invest 1998; 15: 263–269
- Guex-Croisier Y, Herbort D, Nussbaum R, et al. Double clinical blind study with lomefloxacin 0.3% b.i.d. versus gentamycin q.i.d. for patients with acute bacterial conjunctivitis. Poster Presented at the Society of Ophthalmology (SOG) Congress, AarauSwitzerland, 1994
- Yamada M, Ishikawa K, Mochizuki H, et al. Corneal penetration of simultaneously applied topical levofloxacin, norfloxacin, and lomefloxacin in human eyes. Acta Ophthalmol Scandinav 2006; 84: 192–196
- Snir M, Bachar M, Katz J, et al. Combined propofol sedation with sub-Tenon's lidocaine/mercaine infusion for strabismus surgery in adults. Eye on-line 2007; 21: 1155–1161
- Malet F, Colin J, Jauch A, et al. Bacterial keratitis therapy in guinea pigs with lomefloxacin by initially high- followed by low-dosage regimen. Ophthalmic Res 1995; 27: 322–329